SDM laser effective for CSC

Article

According to recently published data, an 810 nm subthreshold diode micropulse (SDM) laser is effective in the treatment of chronic central serous chorioretinopathy (CSC).

According to recently published data, an 810 nm subthreshold diode micropulse (SDM) laser is effective in the treatment of chronic central serous chorioretinopathy (CSC).

The study, performed by Dr Luiz Roisman et al. (Federal University of Sao Paulo, Brazil), included 15 patients in total who were randomized into two groups to either receive SDM laser treatment or a sham procedure.

Ten patients received SDM laser treatment along the detached area, the remaining five patients received sham treatment. At 3 months follow up, the best-corrected visual acuity (BCVA) was found to be significantly improved in the laser treatment group. All patients allocated to the sham group required treatment after 3 months. Central macular thickness was noted to be better in both groups.

It was concluded that SDM laser treatment was effective in the treatment of chronic CSC without causing any damage to the retina.

For more detailed information please view the abstract in Ophthalmic Surgery, Lasers and Imaging.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.